Digital Health Drug Repository Release 2 Specification – FHIR | Call for Participation June 21- July 20, 2017

BACKGROUND:

The Digital Health Drug Repository (DHDR) data is a key element of the EHR and represents approximately 70 per cent of the total dispensed medications in Ontario. It will improve patient care by giving authorized clinicians secure electronic access to a patient's drug information, allowing more time for diagnosis, treatment and communication with patients, and improving patient outcomes by decreasing the risk of adverse drug events.
The DHDR consists of:
• A database of drug dispensations, sourced from Ontario Drugs Benefit (ODB) pharmaceutical and professional service claims data, and from the Narcotics Monitoring System (NMS).
• Privacy consent enforcement using historical ODB consent directives and Publish & Subscribe (PubSub) integration with eHealth Ontario’s Consent Management Technology Asset (CMTA).
The DHDR Release 2 specification includes:
• DHDR FHIR Implementation Guide
o Guidance for implementations supporting FHIR (Fast Healthcare Interoperability Resources) messages (Query, Override)
o Sample messages
• Terminology (Vocabulary) Worksheet

HOW TO PARTICIPATE:

The open review comment period will start as of June 21 and continue until July 20, 2017. A webinar will be held on Tuesday June 27th - from noon to 1 pm – to walk participants through the content and provide information on how to provide comments. Email eHealth Ontario for details or to attend at This email address is being protected from spambots. You need JavaScript enabled to view it.

Here’s the link to the DHDR R2 Specification:
www.ehealthontario.on.ca/en/standards/view/digital-health-drug-repository-specification-fhir-r2